Novo Nordisk: Is This Your Rainy Day Fund? I Think So! (NYSE:NVO)
Ozempic and Wegovy, Novo Nordisk's Weight Loss Drugs, Reshape Denmark's Economy - The New York Times
Novo Nordisk grows GLP-1 market share in Q2 in the US with Ozempic® and Rybelsus® - MidgardFinance.com
Anti-obesity drugs can shrink more than patients
Ozempic, Wegovy maker Novo Nordisk is now the largest company in Europe, by market cap
Novo Nordisk: Super Focused Pharma Company For The Long Run (OTCPK:NONOF)
Ozempic-maker Novo Nordisk briefly becomes Europe's most valuable firm
Chartr Newsletter: Aug 30, 2023
Novo Nordisk (NVO) Q3 Earnings and Sales Beat, 2023 View Up